Cosmeceuticals based on Rhealba® Oat plantlet extract for the treatment of acne vulgaris by Fabbrocini, G & Saint Aroman, M.
Cosmeceuticals based on Rhealba (R) Oat plantlet extract for the treatment of acne vulgaris 
 
By:Fabbrocini, G (Fabbrocini, G.)[ 1 ] ; Saint Aroman, M (Saint Aroman, M.)[ 2 ] 
 
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 
 
Volume: 28 
 
Pages: 1-6 
 
Supplement: 6 
 
Special Issue: SI 
 
DOI: 10.1111/jdv.12791 
 
Published: DEC 2014 
 
View Journal Information 
Abstract 
 
Recent evidence suggests that acne vulgaris begins as an inflammation in and around the sebaceous gland 
and alterations in the lipid content of sebum, which drive hyperproliferation and increased desquamation 
of keratinocytes within sebaceous follicles. This prevents sebum drainage, causing the formation of 
microcomedones, which spontaneously regress or become acne lesions when the pilosebaceous unit is 
further blocked by the accumulation of corneocytes. These conditions are favourable for the proliferation 
of Propionibacterium acnes, which further aggravates acne by enhancing abnormal desquamation, sebum 
production and inflammation. Also, skin fragility due to inflammation or irritation by anti-comedogenic 
agents can worsen the situation. Rhealba((R)) Oat plantlet extract (Pierre Fabre Dermo Cosmetique) 
soothes and restores fragile skin in acne by reducing inflammation and inhibits bacterial adhesion of 
Propionibacterium acnes. Cosmeceuticals combining Rhealba((R)) Oat plantlet extract and hydro-
compensating actives, which are available with or without anti-comedogenic hydroxy acids, provide a 
balanced, multifaceted approach for acne patients. 
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